{
    "organizations": [],
    "uuid": "53c4eec202b73b90cb67a05e3eecf251f0891fb8",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-trovagene-completes-first-dosing-c/brief-trovagene-completes-first-dosing-cohort-of-patients-in-phase-1b-2-trial-of-pcm-075-idUSASC0A2RQ",
    "ord_in_thread": 0,
    "title": "BRIEF-Trovagene Completes First Dosing Cohort Of Patients In Phase 1B/2 Trial Of PCM-075",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 17 (Reuters) - Trovagene Inc:\n* TROVAGENE ANNOUNCES COMPLETION OF FIRST DOSING COHORT OF PATIENTS IN ONGOING PHASE 1B/2 TRIAL OF PCM-075 IN ACUTE MYELOID LEUKEMIA Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-17T20:23:00.000+03:00",
    "crawled": "2018-05-18T19:48:02.017+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "trovagene",
        "inc",
        "trovagene",
        "announces",
        "completion",
        "first",
        "dosing",
        "cohort",
        "patient",
        "ongoing",
        "phase",
        "trial",
        "acute",
        "myeloid",
        "leukemia",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}